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In the past decade, there have been remarkable advances in our understanding of the calcium
messenger system that mediates the effects of various agonists. The purpose of the present
article is to describe two areas of current interest in the calcium signaling field-quantal
calcium release and calcium entry into the cell-using the pancreatic acinar cell as a model.
Proposed mechanisms describing these phenomena and the role they play in the kinetics of
calcium movements in the cell are discussed.
OVERVIEW
The major function of the pancreatic acinar cell is to synthesize, store, and release
digestive enzymes [1]. The regulated secretion of digestive enzymes occurs in
response to a number of hormones and neurotransmitters [2,3]. The intracellular
messenger systems mediating secretion are of two separate types. Agents such as
vasoactive intestinal polypeptide and secretin cause secretion by activating adenylate
cyclase and increasing cyclic AMP. In contrast, cholinergic agents, cholecystokinin,
bombesin peptides, and substance P peptides activate phosphoinositide breakdown
and calcium transports. These processes, in turn, mediate enzyme secretion.
Historically, the pancreatic acinar cell has furnished an important model in
providing the initial observations about the phosphoinositide/calcium pathway. The
initial observation of phosphatidyinositol turnover was made, using pigeon pancre-
atic slices, by the Hokins in 1953 [4]. Inositol 1,4,5-trisphosphate was first demon-
strated to mobilize intracellular calcium stores by Streb et al. in 1983, using
permeabilized pancreatic acinar cells [5]. It is now generally accepted that agonists
such as cholecystokinin, cholinergic agents, bombesin peptides, and substance P
peptides cause a phospholipase C-mediated hydrolysis of the phosphorylated phos-
phatidylinositol derivative, phosphatidylinositol 4,5-bisphosphate, to inositol 1,4,5-
trisphosphate (IP3) and 1,2-diacylglycerol [3,6-8]. IP3, in turn, mobilizes calcium
from an internal store [5,9], while 1,2-diacylglycerol activates protein kinase C [6-8].
The release of calcium from the internal stores by the agonist is both rapid and
transient. Calcium release occurs within one to a few seconds, depending on the
concentration of agonist [10-14]. The release results in a rapid rise in free intracellu-
lar [Ca2+] ([Ca2+]i) [10-14]. The increase in [Ca2+]i causes activation of a plasma
membrane Ca2+ ATPase, resulting in Ca2+ efflux from the cell and a return of [Ca2+]i
toward resting levels [15]. Return of [Ca2+]i toward resting level takes place over an
interval of three to five minutes [10-14].
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After release of the intracellular pool of Ca2 , there is activation of Ca2+ entry
across the plasma membrane [3,16]. This calcium entry results in a sustained level of
[Ca2+]i during stimulation after the initial internal release. The level of [Ca2+]i
during sustained stimulation depends on the concentration of extracellular CaCl2
[17]. Both the internal Ca2+ release and Ca2+ entry have essential roles in mediating
enzyme secretion. The release of intracellular Ca2+ by agonists or Ca2+ ionophores
causes a burst in enzyme secretion, lasting about as long as the transient increase in
[Ca2+]i [6,10,17]. These results indicate that intracellular Ca2+ release alone causes
secretion. During sustained agonist stimulation, a continued increase in enzyme
secretion is dependent on extracellular CaCl2. That is, in the absence of extracellular
Ca2+, enzyme secretory rates return to resting levels after the transient increase in
[Ca2+]i [3,17].
Small concentrations of cholecystokinin-octapeptide, acetylcholine analogs, and
maximally effective concentrations of the cholecystokinin analog, JMV-180, cause
sustained oscillations of [Ca2+]i in the acinar cell [18-20]. Although the mechanism
of the [Ca2+]i oscillations is controversial, one would expect that each oscillatory
increase in [Ca2+]i would stimulate a burst in enzyme secretion.
QUANTAL CALCIUM RELEASE
Compared to a maximally effective dose, one would expect that release of calcium
from intracellular stores by submaximally effective doses of agonist or inositol
1,4,5-trisphosphate would occur at a slower rate but result in a complete release.
Observations from several laboratories indicate that this process is not the case
[21-26]. Both submaximally effective and maximally effective concentrations cause
rapid and transient release of calcium from the intracellular stores. The release by a
submaximally effective concentration is partial despite continued presence of agonist
or inositol 1,4,5-trisphosphate. This phenomenon has been called "quantal Ca2+
release."
There have been several models proposed to account for the cellular mechanism
of quantal calcium release. To date, none have been generally accepted. In one
model [21,23,27], it was proposed that the Ca2+ stores have varying sensitivities to
inositol 1,4,5-trisphosphate-induced Ca2+ release; that is, some compartments have a
high sensitivity to IP3 and release all of their Ca2+ with a low concentration of IP3.
Other stores have lower sensitivities to IP3 and require greater concentrations of IP3
to release Ca2+. A continuous gradient of sensitivities of the stores to IP3, then,
would account for the observed effects of both IP3 and the agonist.
In a variant of the above model [28-31], Irvine has proposed that the Ca2+ content
of the internal store regulates its sensitivity to IP3-induced Ca2+ release. In this
model, the entire pool is responsive to a submaximal concentration of IP3. The
resulting Ca2+ release decreases the pool Ca2+ content, which, in turn, decreases the
responsiveness of the pool to IP3-induced Ca2+ release. Thus, a greater concentra-
tion of IP3 would be necessary to release the remainder of the Ca2+ from the store. In
a third model [25,32], it has been proposed that, with a continuous IP3 stimulation,
there is a conversion of the Ca2+-releasing channel on the pool from an active to an
inactive state, independent of the Ca2+ content of the pool.
Although published reports describe the phenomenon of quantal Ca2+ release in a
variety of tissues, there has been no general agreement on the mechanism. The
experimental strategy commonly used to determine whether Ca2+ depletion of the
400
CALCIUM AND THE PANCREAS
pool results in a decrease in the sensitivity of the pool to IP3 has been first to partially
deplete the pool of Ca2+ with Ca2+ ionophores or IP3, followed by a measurement of
the potency of IP3 to release the remaining Ca2+ [26,27,29-31]. In some [26,30,31]
but not all [27] of these studies, results have been presented suggesting that luminal
Ca2+ regulates the sensitivity of Ca2+ release to IP3.
Using dispersed pancreatic acini, we found that the potency of cholecystokinin-
octapeptide (CCK-OP) to release Ca2+ from intracellular stores was unaltered by
partial Ca2+ depletion of the stores by a pre-stimulation with carbachol [33]. Because
carbachol and CCK-OP released Ca2+ from the same pool [10], these results
suggested that quantal release in the pancreatic acinar cell was not due to either
changing sensitivities of the pool to IP3 as a function of Ca2+ content or various
compartments with different sensitivities to IP3.
Of particular interest to this field was a recent experiment demonstrating that
quantal release occurred in lipid vesicles containing only purified IP3 receptors [25].
The quantal release phenomenon was independent of vesicular Ca2+ content.
Because the IP3 receptor contains the Ca2+ channel mediating IP3 effects on Ca2+
release [34], these results indicated that quantal release is an intrinsic characteristic
of the receptor.
As illustrated above, the biochemical mechanism of quantal Ca2+ release has not
been completely determined; however, the phenomenon of quantal release may
provide an important physiologic control. For example, as discussed earlier, the
pancreatic acinar cell contains several receptor classes that mediate Ca2+ release.
Successive applications of submaximally effective (physiologic) concentrations of
agonists interacting with a different class of receptors on the cell would result in
transient increases in [Ca2+]i, and each rise in [Ca2+]i could cause a cellular
response. A demonstration of such an effect has not yet been provided in the
literature.
CALCIUM ENTRY
For cells containing non-voltage-regulated Ca2+ entry mechanisms, it is now
generally accepted that the plasma membrane Ca2+ transport is regulated by the
intracellular Ca2+ store [35,36]. Specifically, depletion of the intracellular store by
IP3-induced Ca2+ release causes activation of the plasma membrane influx mecha-
nism. This mechanism has been referred to as the "capacitative model" by Putney
[35,36].
This model was proposed to account for the generally observed coupling between
intracellular Ca2+ release and cell Ca2+ entry in a variety of tissues [37-39]. Soon
after the discovery that the initial action of the agonist was to cause formation of IP3
which, in turn, released intracellular Ca2+ stores [40,41], Putney attempted to explain
the coupling in his first variation of the "capacitance" model [35]. In this model, he
proposed that depletion of the pool activated the pathway for Ca2+ entry because the
pool signaled the entry mechanism, using a close anatomic relationship between the
pool and the plasma membrane Ca2+ influx mechanism. The Ca2+ entered the pool
directly after crossing the plasma membrane. The depletion-activated Ca2+ influx,
would, in turn, provide Ca2+ for refilling the intracellular store. During continued
stimulation, Ca2+ release from the store would provide a source of Ca2+ to be
released into the cytoplasm.
Observations since Putney's first proposal suggested that Ca2+ does not enter the
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pool directly after influx across the plasma membrane. Experiments in both pancre-
atic acinar cells and parietal cells demonstrated that there was a mechanism for store
uptake of Ca2+ from the cytoplasm [41-44]. In these experiments, agonist action was
terminated just after release of Ca2+ from the store and before the Ca2+ was effiluxed
from the cell. The termination of agonist action resulted in complete reloading of the
stores from the cytoplasmic Ca2+. Muallem et al. [43] demonstrated that intracellular
Ca2+ buffers decreased the rate of refilling of the intracellular Ca2+ pools in
pancreatic acini, also suggesting that the route of refilling was cytoplasmic.
Experiments using the tumor promoter, thapsigargin, also suggested that the
depleted pool stimulated Ca2+ entry directly into the cytoplasm. Thapsigargin is a
pharmacologic tool that depletes intracellular stores by inhibiting the Ca2+-ATPase
responsible for loading the stores [45] without raising the levels of intracellular
inositol phosphates [46]. When thapsigargin was used to deplete intracellular stores,[Ca2+]i increased when extracellular Ca2+ was present [47]. In addition to indicating
that Ca2+ entry was into the cytoplasm, these results suggested that inositol phos-
phates are not necessary for Ca2+ entry.
The most challenging issue at present is the elucidation of the mechanism by which
depletion of the internal stores signals the plasma membrane Ca2+ influx mechanism.
We have presented evidence that cyclic GMP may act to mediate activation of the
Ca2+ entry mechanism in the pancreatic acinar cell [48]. In brief, in pancreatic acinar
cells, as well as in other tissues, agonists that mobilize intracellular Ca2+ also cause
an increase in cyclic GMP [49,50]. We found that a pharmacologic agent, LY83583,
could inhibit the ability of the agonist, carbachol, to increase cyclic GMP without
altering Ca2+ mobilization by carbachol [48]; however, LY83583 inhibited Ca2+ entry
during carbachol stimulation and refilling of the intracellular pools at the termina-
tion of carbachol stimulation. The inhibition of refilling was due to a blockade of the
plasma membrane Ca2+ entry mechanism. Recent experiments suggest that deple-
tion of the intracellular Ca2+ stores by thapsigargin results in increased cellular cyclic
GMP [51]. The studies to date do not indicate how intracellular stores regulate cyclic
GMP formation or how cyclic GMP activates the Ca2+ entry mechanism. The
findings suggest, however, that the increase in cyclic GMP during agonist stimulation
is both necessary and sufficient to activate the Ca2+ entry mechanism.
Irvine has proposed that the phosphorylated metabolite of IP3, inositol 1,3,4,5-
tetrakisphosphate (IP4), has a role in mediating Ca2+ entry [52-54]. This proposal
came initially from observations in sea urchin eggs, where it was found that the full
fertilization response could be elicited with a combination of IP3 and IP4 in the
presence of external Ca2+ [52]. IP3 alone was insufficient. Subsequently, electrophys-
iologic studies of Ca2+-activated K+ channels in lacrimal cells demonstrated that IP3
alone caused only a transient activation [53,54]. The addition of IP4 and external
Ca2+ were necessary for sustained activation [53,54]. Although these results suggest a
possible role for IP4 in mediating Ca2+ influx, they contradict the interpretation of
findings with thapsigargin discussed earlier. That is, thapsigargin depletes internal
stores and activates Ca2+ influx without changing cellular inositol phosphates. Thus,
it is probable that IP4 is not necessary for regulation of the influx mechanism.
In conclusion, the weight of the evidence suggests that Ca2+ influx in non-excitable
cells is activated by IP3-induced depletion of intracellular Ca2+ stores. The Ca2+
enters across the plasma membrane into the cytoplasm, where it maintains [Ca2+]i
and provides a source of Ca2+ for reloading the internal stores. The nature of the
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mechanism mediating the communication between the stores and the plasma mem-
brane has not been established. We have proposed a role for cyclic GMP in this
process. Further work is necessary to complete this story.
REFERENCES
1. Palade G: Intracellular aspects of the process of protein synthesis. Science 189:347-358, 1975
2. Gardner JD, Jensen RT: Secretagogue receptors on pancreatic acinar cells. In Physiology of the
Gastrointestinal Tract, Second Edition. Edited by LR Johnson. New York, Raven, 1987, pp 1109-
1128
3. Hootman SR, Williams JA: Stimulus secretion coupling in the pancreatic acinus. In Physiology of the
Gastrointestinal Tract, Second Edition. Edited by LR Johnson. New York, Raven, 1987, pp 1129-
1146
4. Hokin MR, Hokin LE: Enzyme secretion and incorporation of p32 into phospholipids pancreas slices.
J Biol Chem 203:967-977, 1953
5. Streb H, Irvine RF, Berridge MJ, Schultz I: Release of Ca2+ from a nonmitochondrial intracellular
store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature (London) 306:67-69, 1983
6. Bruzzone R: The molecular basis of enzyme secretion. Gastroenterology 99:1157-1176, 1990
7. Pandol SJ, Schoeffield MS: 1,2-diacylglycerol, protein kinase C and pancreatic enzyme secretion. J
Biol Chem 261:4438-4444, 1986
8. Matozaki T, Williams JA: Multiple sources of 1,2-diacylglycerol in isolated rat pancreatic acini
stimulated by cholecystokinin. Involvement of phosphatidylinositol bisphosphate and phosphatidylcho-
line hydrolysis. J Biol Chem 264:12729-12734, 1989
9. Berridge MJ, Irvine RF: Inositol phosphates and cell signalling. Nature (London) 341:197-205, 1989
10. Pandol SJ, Schoeffield MS, Sachs G, Muallem S: Role of free cytosolic calcium in secretagogue-
stimulated amylase release from dispersed acini from guinea pig pancreas. J Biol Chem 260:10081-
10086, 1985
11. Powers RE, Johnson PC, Houlihan MJ, Saluja AK, Steer ML: Intracellular Ca2+ levels and amylase
secretion in quin-2-loaded mouse pancreatic acini. Am J Physiol 248 (Cell Physiology 17):C535-C541,
1985
12. Ochs DL, Korenbrot JI, Williams JA: Relationship between agonist-induced changes in the concen-
tration of free intracellular calcium and secretion of amylase by pancreatic acini. Am J Physiol 249
(Gastrointestinal Liver Physiology 12):G389-G398, 1985
13. Merritt JE, Rubin RP: Pancreatic enzyme secretion and cytosolic free calcium. Effects of ionomycin,
phorbol dibutyrate and diacylglycerol alone and in combination. Biochem J 230:151-159, 1985
14. Bruzzone R, Pozzan T, Wollheim CB: Caerulein and carbamoylcholine stimulate pancreatic amylase
release at resting cytosolic free Ca2+. Biochem J 235:139-143, 1986
15. Muallem S, Beeker TG, Pandol SJ: Role of Na+/Ca2+ exchange and the plasma membrane Ca2+
pump in hormone-mediated Ca2+ efflux from pancreatic acini. J Membrane Biol 102:153-162, 1988
16. Pandol SJ, Schoeffield MS, Fimmel CJ, Muallem S: The agonist-sensitive calcium pool in the
pancreatic acinar cell. Activation of plasma membrane Ca2+ influx mechanism. J Biol Chem
262:16963-16968, 1987
17. Krims PE, Pandol SJ: Free cytosolic calcium and secretagogue-stimulated initial pancreatic exocrine
secretion. Pancreas 3:383-390, 1988
18. Matozaki T, Goke B, Tsunoda Y, Rodriguez M, Martinez J, Williams JA: Two functionally distinct
cholecystokinin receptors show different modes of action on Ca2+ mobilization and phospholipid
hydrolysis in isolated rat pancreatic acini studies using a new cholecystokinin analog, JMV-180. J Biol
Chem 265:6247-6254, 1990
19. Osipchuk YV, Wakui M, Yule DI, Gallacher DU, Petersen OH: Cytoplasmic Ca2+ oscillations evoked
by receptor stimulation, G-protein activation, internal application of inositol trisphosphate or
Ca2+:Simultaneous microfluorimetry and Ca2+ dependent Cl - current recording in single pancreatic
acinar cells. Embo J 9:697-704, 1990
20. Petersen CC, Toescu EC, Petersen OH: Different patterns of receptor-activated cytoplasmic Ca2+
oscillations in single pancreatic acinar cells: Dependence on receptor types, agonist concentration and
intracellular Ca2+ buffering. Embo J 10:527-533, 1991
21. Muallem S, Pandol SJ, Beeker TG: Hormone-evoked calcium release from intracellular stores is a
quantal process. J Biol Chem 264:205-212, 1989
404 PANDOL AND RUTHERFORD
22. Taylor CW, Potter BVL: The size of inositol 1,4,5-trisphosphate-sensitive Ca2+ stores depends on
inositol 1,4,5-trisphosphate concentration. Biochem J 266:189-194, 1990
23. Oldershaw KA, Nunn DL, Taylor CW: Quantal Ca2+ mobilization stimulated by inositol 1,4,5-
trisphosphate in permeabilized hepatocytes. Biochem J 278:705-708, 1991
24. Meyer T, Stryer L: Transient calcium release induced by successive increments of inositol 1,4,5-
trisphosphate. Proc Natl Acad Sci USA 87:3841-3845, 1990
25. Ferris CD, Cameron AM, Huganir RL, Synder SH: Quantal calcium release by purified reconstituted
inositol 1,4,5-trisphosphate receptors. Nature 356:350-352, 1992
26. Missiaen L, De Smedt H, Droogmans G, Casteels R: Ca2+ release induced by inositol 1,4,5-
trisphosphate is a steady-state phenomenon controlled by luminal Ca2+ in permeabilized cells. Nature
357:599-602, 1992
27. Combettes L, Claret M, Champeil P: Do submaximal InsP3 concentrations only induce the partial
discharge of permeabilized hepatocyte calcium pools because of the concomitant reduction of
intraluminal Ca2+ concentration? FEBS Lett 301:287-290, 1992
28. Irvine RF: "Quantal" Ca2+ release and the control of Ca2+ entry by inositol phosphates-a possible
mechanism. FEBS Lett 263:5-9, 1990
29. Tregear RT, Dawson AP, Irvine RF: Quantal release of Ca2+ from intracellular stores by Ins P3: Tests
of the concept of control of Ca2+ release by intraluminal Ca2+. Proc Royal Soc London (Series B,
Biological Sciences) 243:263-268, 1991
30. Nunn DL, Taylor CW: Luminal Ca2+ increases the sensitivity of Ca2+ stores to inositol 1,4,5-
trisphosphate. Mol Pharmacol 41:115-119, 1992
31. Missiaen L, De Smedt H, Droogmans G, Casteels R: Ca2+ release induced by inositol 1,4,5-
trisphosphate is a steady-state phenomenon controlled by luminal Ca2+ in permeabilized cells. Nature
357:599-602, 1992
32. Swillens S: Dynamic control of inositol 1,4,5-trisphosphate-induced Ca2+ release: A theoretical
explanation for the quantal release of Ca2+. Mol Pharmacol 41:110-114, 1992
33. Rutherford RE, Pandol SJ: Rapid desensitization of calcium release from the agonist-sensitive pool in
pancreatic acinar cells (Abstract). Gastroenterology 98:A520, 1990
34. Ferris CD, Huganir RL, Supattapone S, Synder SH: Purified inositol 1,4,5-trisphosphate receptor
mediates calcium flux in reconstituted lipid vesicles. Nature 342:87-89, 1989
35. Putney JW Jr: A model for receptor-regulated calcium entry. Cell Calcium 7:1-2, 1986
36. Putney JW Jr: Capacitative calcium entry revisited. Review article. Cell Calcium 11:611-624, 1990
37. Putney JW Jr: Biphasic modulation of potassium release in rat parotid gland by carbachol and
phenylephrine. J Pharmacol Exp Ther 198:375-384, 1976
38. Stolze H, Schulz I: Effect of atropine, ouabain, antimycin A and A23187 on trigger Ca2+ pool in
exocrine pancreas. Am J Physiol 238:G338-G348, 1980
39. DeWitt LM, Putney JW Jr: Alpha adrenergic stimulation of potassium efflux in guinea pig hepatocytes
may involve calcium influx and calcium release. J Physiol 346:395-407, 1989
40. Streb H, Irvine RF, Berridge MJ, Schultz I: Release of Ca2+ from a nonmitochondrial store in
pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306:67-68, 1983
41. Berridge MJ, Irvine RF: Inositol phosphates and cell signalling. Nature 341:197-205, 1989
42. Muallem S, Schoeffield MS, Fimmel CJ, Pandol SJ: Agonist-sensitive calcium pool in the pancreatic
acinar cell. II. Characterization of reloading. Am J Physiol 255(Gastrointestinal Liver Physiology
18):G229-G235, 1988
43. Muallem S, Khademazad M, Sachs G: The route of Ca2+ entry during reloading of the intracellular
Ca2+ pool in pancreatic acini. J Biol Chem 265:2011-2016, 1990
44. Machen TE, Negulescu PA: Release and reloading of intracellular Ca2+ stores after cholinergic
stimulation of the parietal cell. Am J Physiol 254:C498-C504, 1988
45. Thastrup 0, Cullen PJ, Drobak DK, Hanley MR, Dawson AP: Thapsigargin, a tumor promoter
discharges intracellular Ca2+ stores by specific inhibition of endoplasmic reticulum Ca2+ ATPase.
Proc Natl Acad Sci USA 87:2466-2470, 1990
46. Jackson TR, Patterson SI, Thastrup 0, Hanley MR: A novel tumor promotor, thapsigargin, tran-
siently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L
neuronal cells. Biochem J 253:81-86, 1988
47. Takemura H, Hughes AR, Thastrup 0, Putney JW Jr: Activation of calcium entry by the tumor
promotor, thapsigargin, in parotid acinar cells. Evidence that an intracellular calcium pool, and not an
inositol phosphate, regulates calcium fluxes at the plasma membrane. J Biol Chem 264:12266-12272,
1989
CALCIUM AND THE PANCREAS 405
48. Pandol SJ, Schoeffield-Payne MS: Cyclic GMP mediates the agonist-stimulated increase in plasma
membrane calcium entry in the pancreatic acinar cell. J Biol Chem 265:12846-12853, 1990
49. DeMeyts P, Hanoune J: Plasma membrane receptors and function. In The Liver: Biology and
Pathobiology. Edited by I Arias, H Popper, D Schacter, DA Shafritz. New York, Raven, 1982, pp
551-580
50. Young JA, Cook DI, van Lennep EW, Roberts M: Secretion of the major salivary glands. In
Physiology of the Gastrointestinal Tract, Second Edition. Edited by LR Johnson. New York, Raven,
1987, pp 773-816
51. Pandol SJ, Schoeffield-Payne MS: The agonist-sensitive pool of calcium regulates cellular cyclic GMP
in the pancreatic acinar cell (Abstract). Gastroenterology 102:A284, 1992
52. Irvine RF, Moore RM: Micro-injection of inositol 1,3,4,5-tetrakisphosphate activates sea urchin eggs
by a mechanism dependent on external Ca2+. Biochem J 240:917-920, 1986
53. Morris AP, Gallacher DV, Irvine RF, Petersen OH: Synergism of inositol trisphosphate and
tetrakisphosphate in activating Ca2+-dependent K+ channels. Nature 330:653-655, 1987
54. Chanyga L, Gallacher DV, Irvine RF, Potter BVL, Petersen OH: Inositol 1,3,4,5-trisphosphate is
essential for sustained activation of the Ca2+-dependent K+ current in single internally perfused
lacrimal cells. J Membrane Biol 109:85-93, 1989
